The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: A comparison with tianeptine

Biological Psychiatry

Volumn 55, Issue 12, 2004, Pages 1171-1178

  Burghardt, Nesha S ^a   Sullivan, Gregory M ^b   McEwen, Bruce S ^c   Gorman, Jack M ^d   Ledoux, Joseph E ^a  

^a NEW YORK UNIVERSITY   (United States)

^b Columbia Coll of Phys and Surgeons ^*  (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

amygdala; anxiety; citalopram; Fear conditioning; serotonin; tianeptine

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; AUDITORY STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEAR; INSTRUMENTAL CONDITIONING; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT COURSE THERAPY;

ACOUSTIC STIMULATION; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; CONDITIONING (PSYCHOLOGY); FEAR; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; RATS; RATS, SPRAGUE-DAWLEY; THIAZEPINES; TIME FACTORS;

EID: 2942590540     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.02.029     Document Type: Article

References (64)

1. Alby J.M., Ferreri M., Cabanne J., De Bodinat C., Dagens V. Efficacy of tianeptine (Stablon) for the treatment of major depression and dysthymea with somatic complaint. A comparative study versus fluoxetine (Prozac). Ann Psychiatry. 8:1993;136-144
2. Attenburrow M.J., Williams C., Odontiadis J., Reed A., Powell J., Cowen P.J., Harmer C.J. Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology (Berl). 169:2003;104-107
3. Avanzi V., Brandao M.L. Activation of somatodendritic 5-HT(1A) autoreceptors in the median raphe nucleus disrupts the contextual conditioning in rats. Behav Brain Res. 126:2001;175-184
4. Bezchlibnyk-Butler K., Aleksic I., Kennedy S.H. Citalopram - a review of pharmacological and clinical effects. J Psychiatry Neurosci. 25:2000;241-254
5. Blier P. Pharmacology of rapid-onset antidepressant treatment strategies. J Clin Psychiatry. 62:(suppl 15):2001;12-17
6. Blier P., Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol. 15:1995;217-222
7. Boyer W.F., Feighner J.P. An overview of paroxetine. J Clin Psychiatry. 53:(suppl):1992;3-6
8. Castanon N., Bluthe R.M., Dantzer R. Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology. 154:2001;50-60
9. Cheng L.L., Wang S.J., Gean P.W. Serotonin depresses excitatory synap-tic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors. Eur J Neurosci. 10:1998;2163-2172
10. Conrad C.D., Galea L.A., Kuroda Y., McEwen B.S. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci. 110:1996;1321-1334
11. Conrad C.D., LeDoux J.E., Magarinos A.M., McEwen B.S. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci. 113:1999;902-913
12. Datla K.P., Curzon G. Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine. Neuropharmacology. 32:1993;839-845
13. De Bellis M.D., Casey B.J., Dahl R.E., Birmaher B., Williamson D.E., Thomas K.M., et al. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol Psychiatry. 48:2000;51-57
14. Durand M., Berton O., Aguerre S., Edno L., Combourieu I., Mormede P., Chaouloff F. Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis in SHR and WKY rats. Neuropharmacology. 38:1999;893-907
15. Feighner J.P., Boyer W.F. Selective Serotonin Re-uptake Inhibitors The Clinical use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline. 1991;John Wiley & Sons, New York
16. File S., Mabbutt P. Effects of tianeptine in animal models of anxiety and on learning and memory. Drug Dev Res. 23:1991;47-56
17. Gehlert D.R., Gackenheimer S.L., Wong D.T., Robertson D.W. Localization of 5-HT3 receptors in the rat brain using [3H]LY278584. Brain Res. 553:1991;149-154
18. Goldstein B.J., Goodnick P.J. Selective serotonin reuptake inhibitors in the treatment of affective disorders - III. Tolerability, safety and pharmacoeconomics. J Psychopharmacol. 12:1998;S55-S87
19. Gorman J.M., Liebowitz M.R., Fyer A.J., Goetz D., Campeas R.B., Fyer M.R., et al. An open trial of fluoxetine in the treatment of panic attacks [erratum appears in J Clin Psychopharmacol 1988;8:13]. J Clin Psychopharmacol. 7:1987;329-332
20. Griebel G., Blanchard D.C., Agnes R.S., Blanchard R.J. Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology. 120:1995;57-66
21. Griebel G., Moreau J.L., Jenck F., Misslin R., Martin J.R. Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology. 113:1994;463-470
22. Guelfi J.D., Pichot P., Dreyfus J.F. Efficacy of tianeptine in anxious-depressed patients Results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology. 22:1989;41-48
23. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 297:2002;400-403. [comment]
24. Harmer C.J., Bhagwagar Z., Cowen P.J., Goodwin G.M. Acute administration of citalopram facilitates memory consolidation in healthy volunteers. Psychopharmacology. 163:2002;106-110
25. Harmer C.J., Bhagwagar Z., Perrett D.I., Vollm B.A., Cowen P.J., Goodwin G.M. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology. 28:2003;148-152. [comment]
26. Harmer C.J., Rogers R.D., Tunbridge E., Cowen P.J., Goodwin G.M. Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology. 167:2003;411-417
27. Inoue T., Hashimoto S., Tsuchiya K., Izumi T., Ohmori T., Koyama T. Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing. Eur J Pharmacol. 311:1996;1-6
28. Kelly J.P., Leonard B.E. The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology. 33:1994;1011-1016
29. Kim J.J., Fanselow M.S. Modality-specific retrograde amnesia of fear. Science. 256:1992;675-677
30. Korzeniewska-Rybicka I., Plaznik A. Analgesic effect of antidepressant drugs. Pharmacol Biochem Behav. 59:1998;331-338
31. Labrid C, Mocaer E, Kamoun A (1992): Neurochemical and pharmacological properties of tianeptine, a novel antidepressant. Br J Psychiatry Suppl(15):56-60
32. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci. 23:2000;155-184
33. Lepine J.P., Altamura C., Ansseau M., Gutierrez J.L., Bitter I., Lader M., Waintraub L. Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression An international, 6-week double-blind study dagger. Hum Psychopharmacol. 16:2001;219-227
34. Li X.B., Inoue T., Hashimoto S., Koyama T. Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur J Pharmacol. 425:2001;43-50
35. Maren S. Is there savings for pavlovian fear conditioning after neurotoxic basolateral amygdala lesions in rats? Neurobiol Learn Mem. 76:2001;268-283
36. Masand P.S., Gupta S. Selective serotonin-reuptake inhibitors An update. Harv Rev Psychiatry. 7:1999;69-84
37. Matto V., Allikmets L. Acute and chronic citalopram treatment differently modulates rat exploratory behavior in the exploration box test No evidence for increased anxiety or changes in the [3H]raclopride binding. Pharmacology. 58:1999;59-69
38. Morris J.S., Frith C.D., Perrett D.I., Rowland D., Young A.W., Calder A.J., Dolan R.J. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature. 383:1996;812-815
39. Morris R.G., Kelly S., Burney D., Anthony T., Boyer P.A., Spedding M. Tianeptine and its enantiomers Effects on spatial memory in rats with medial septum lesions. Neuropharmacology. 41:2001;272-281
40. Nader K., LeDoux J. The dopaminergic modulation of fear Quinpirole impairs the recall of emotional memories in rats. Behav Neurosci. 113:1999;152-165
41. Nelson C.J., Jordan W.P., Bohan R.T. Daily fluoxetine administration impairs avoidance learning in the rat without altering sensory thresholds. Prog Neuropsychopharmacol Biol Psychiatry. 21:1997;1043-1057
42. Nieuwenhuys R. Chemoarchitecture of the Brain. 1985;Springer-Verlag, Berlin
43. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 106:1992;274-285
44. Pompeiano M., Palacios J.M., Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs Comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res. 23:1994;163-178
45. Rauch S.L., Whalen P.J., Shin L.M., McInerney S.C., Macklin M.L., Lasko N.B., et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder A functional MRI study. Biol Psychiatry. 47:2000;769-776
46. Rickels K., Rynn M. Pharmacotherapy of generalized anxiety disorder. J Clin Psychiatry. 63:(suppl 14):2002;9-16
47. Rudy J.W. Contextual conditioning and auditory cue conditioning dissociate during development. Behav Neurosci. 107:1993;887-891
48. Sanchez C., Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology. 129:1997;197-205
49. Schafe G.E., Nadel N.V., Sullivan G.M., Harris A., LeDoux J.E. Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. Learn Mem. 6:1999;97-110
50. Schmitt J.A., Kruizinga M.J., Riedel W.J. Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. J Psychopharmacol. 15:2001;173-179
51. Schreiber R., Melon C., De Vry J. The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology. 135:1998;383-391
52. Sheehan D.V., Raj B.A., Trehan R.R., Knapp E.L. Serotonin in panic disorder and social phobia. Int Clin Psychopharmacol. 8:(suppl 2):1993;63-77
53. Shin L.M., Kosslyn S.M., McNally R.J., Alpert N.M., Thompson W.L., Rauch S.L., et al. Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation. Arch Gen Psychiatry. 54:1997;233-241
54. Silva R.C., Brandao M.L. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze An ethological analysis. Pharmacol Biochem Behav. 65:2000;209-216
55. Stiedl O., Misane I., Spiess J., Ogren S.O. Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice. J Neurosci. 20:2000;8515-8527
56. Stutzmann G.E., McEwen B.S., LeDoux J.E. Serotonin modulation of sensory inputs to the lateral amygdala Dependency on corticosterone. J Neurosci. 18:1998;9529-9538
57. van der Kolk B.A., Dreyfuss D., Michaels M., Shera D., Berkowitz R., Fisler R., Saxe G. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 55:1994;517-522. [comment]
58. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol. 313:1991;643-668
59. Vertes R.P., Fortin W.J., Crane A.M. Projections of the median raphe nucleus in the rat. J Comp Neurol. 407:1999;555-582
60. Waintraub L., Septien L., Azoulay P. Efficacy and safety of tianeptine in major depression Evidence from a 3-month controlled clinical trial versus paroxetine. CNS Drugs. 16:2002;65-75
61. Watanabe Y., Gould E., Daniels D.C., Cameron H., McEwen B.S. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol. 222:1992;157-162
62. Wilde M.I., Benfield P. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression [erratum appears in Drugs 1995;50:156]. Drugs. 49:1995;411-439
63. Wilensky AE, Schafe GE, LeDoux JE (1999): Functional inactivation of the amygdala before but not after auditory fear conditioning prevents memory formation. J Neurosci 19:R:C48
64. Zhang Y., Raap D.K., Garcia F., Serres F., Ma Q., Battaglia G., Van de Kar L.D. Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats. Brain Res. 855:2000;58-66